Cervical Health

New research reveals rising non-adherence to cervical cancer screening and declining HPV vaccine awareness since the pandemic.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A study found women with Medicaid insurance are more than twice as likely to experience delays in starting cervical cancer treatment.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Biennial HPV testing and higher vaccination rates could help South Korea eliminate cervical cancer up to a decade earlier than with current policy.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A 13-year randomized trial finds no added benefit from a booster dose in preventing persistent HPV-16 and HPV-18 infections.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

New research reveals increased rates of human papillomavirus infection and cervical cancer in women aged 65 years and older, highlighting the need to reconsider current screening guidelines.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study finds that mailing human papillomavirus self-collection kits, especially with patient navigation support, significantly boosts cervical cancer screening rates.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study shows that a self-collected cervical cancer screening device is highly accurate, easy to use, and preferred over clinician collection.

The Teal Wand offers FDA-approved, accurate at-home cervical cancer screening for women aged 25 to 65 years, aiming to improve access and comfort while boosting screening rates.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study found that while cervical cancer risks remain low for women who meet screening exit criteria, they increase with age and time since last screening.

Vvax001, a new HPV16 vaccine, offers a potential alternative to surgery for treating precancerous cervical lesions, with promising trial results.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Jeff Andrews, MD, FRCSC, discusses troubling trends in cervical cancer mortality and how self-collection could address key barriers to screening, based on a recent BD survey conducted across 4 countries.